INVO Fertility, Inc. (IVF) Stock Forecast
IVF analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 1 analysts
- Price target
- $20.00 average of analyst targets
- Upside to target
- +3,484.2% from the latest close
- Next earnings
- November 16, 2026
- 52-week range
- $0.56 – $27.24
IVF analyst ratings
1 analystsNumber of analysts at each rating.
IVF price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
IVF earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$5.20 | −$5.20 | −$5.20 | — | — | 1 |
| Current fiscal year (2026) | −$23.20 | −$23.20 | −$23.20 | — | — | 1 |
| Next fiscal year (2027) | −$8.00 | −$8.00 | −$8.00 | −$23.20 | +65.5% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
IVF revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.7M | $2.7M | $2.7M | +54.2% | 1 |
| Current fiscal year (2026) | $10.4M | $10.4M | $10.4M | +52.3% | 1 |
| Next fiscal year (2027) | $16.5M | $16.5M | $16.5M | +58.0% | 1 |
IVF EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
IVF revenue: reported and forecast
IVF EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.00 | $0.00 | $0.00 | −$5.20 | — | 0 up · 0 down |
| Current fiscal year (2026) | −$117.60 | −$117.60 | −$117.60 | −$117.60 | −$23.20 | −80.3% | 1 up · 0 down |
| Next fiscal year (2027) | −$220.80 | −$220.80 | −$220.80 | −$220.80 | −$8.00 | −96.4% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
IVF earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; IVF beat in 4 of 7.
What analysts expect from IVF
1 analysts cover INVO Fertility; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $20.00, 3,484.2% above the latest close of $0.56. Analysts expect earnings of −$23.20 per share for 2026. For 2027 the average estimate is −$8.00 per share on revenue of $16.5 million. INVO Fertility beat the EPS estimate in 4 of the last 7 quarters.
Related: IVF income statement, IVF key metrics, IVF chart. See the IVF stock overview for the latest quote and news.
IVF forecast FAQ
What is INVO Fertility's price target?
The average analyst price target for INVO Fertility is $20.00, 3,484.2% above the latest close of $0.56.
Is INVO Fertility a buy, hold or sell?
Of 1 analysts covering INVO Fertility, 0 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is INVO Fertility's EPS forecast?
Analysts forecast −$23.20 per share for 2026 (range −$23.20 to −$23.20); for 2027 the estimate is −$8.00.
What is INVO Fertility's revenue forecast?
The average revenue estimate for 2026 is $10.4 million, growth of 52.3%; for 2027 it is $16.5 million.
When does INVO Fertility report earnings?
INVO Fertility is expected to report results for the quarter ending September 30, 2026 on November 16, 2026.
Does INVO Fertility usually beat earnings estimates?
INVO Fertility reported EPS at or above the analyst estimate in 4 of the last 7 quarters.